A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs

Area of Science:

• Pharmaceutical Sciences
• Biotechnology
• Drug Delivery Systems

Background:

• Liposomal drug delivery systems offer targeted therapeutic potential.
• Developing efficient methods for ligand-functionalization of liposomes is crucial for targeted therapies.
• Steric stabilization of liposomes can improve their stability and circulation time.

Purpose of the Study:

• To develop a versatile and simple method for producing sterically stabilized immunoliposomal drugs (SIL).
• To enable a 'mix and match' combinatorial approach for manufacturing diverse ligand-targeted liposomal drugs.
• To evaluate the efficiency and stability of the developed SIL production method.

Main Methods:

• Ligand-coupled micelles formed from polyethylene glycol (PEG)-lipid derivatives (mPEG2000-DSPE) were used.
• Ligands were transferred from micelles into preformed, drug-containing liposomes in a temperature- and time-dependent manner.
• Antibody densities and PEG-lipid percentages were optimized, and drug leakage and plasma stability were assessed.

Main Results:

• Simultaneous transfer of ligands and PEG-lipids into liposomes was achieved with high antibody densities and PEG-lipid incorporation.
• Negligible drug leakage and good stability in human plasma were observed during the transfer process.
• Sterically stabilized immunoliposomes functionalized with anti-CD19 showed a three-fold increase in binding to CD19+ B cell lymphoma cells.

Conclusions:

• A straightforward and adaptable method for producing sterically stabilized immunoliposomal drugs was successfully developed.
• The 'mix and match' approach facilitates the manufacturing of various ligand-targeted liposomal drugs.
• The enhanced binding of ligand-targeted SIL to cancer cells demonstrates their potential for improved targeted drug delivery and cancer therapy.